| Cat. No. |
Product Name |
Information |
| PC-22652 |
FHND6091
Proteasome inhibitor
|
FHND6091 is the prodrug of FHND6081, which is a potent, selective oral proteasome inhibitor, binds irreversibly to the β5 submit of the 20S proteasome and exerts anti-cancer activities. |
| PC-22651 |
FHND6081
Proteasome inhibitor
|
FHND6081 is a potent, selective oral proteasome inhibitor, binds irreversibly to the β5 submit of the 20S proteasome and exerts anti-cancer activities. |
| PC-22061 |
hRpn13 inhibitor XL44
hRpn13 inhibitor
|
XL44 is a potent, specific hRpn13 (proteasome subunit hRpn13)-binding compound, binds to hRpn13 Pru domain, induces loss of hRpn13 Pru and hRpn13-dependent apoptosis. |
| PC-21189 |
TCL-Ester
Rpn-13 inhibitor
|
TCL-Ester is the cell-permeable derivative of TCL-1, a non-covalent ligand targeting the Pru domain of Rpn-13. |